|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Complement C4d ELISA | Amyloid ß Toxic Oligomer ELISA Assay | Anti-Adalimumab (Humira®) ELISA | Anti-Ustekinumab (Stelara®) ELISA | Thioredoxin ELISA Assay |
| Citations | | | | | |
| Catalog Number | COMPL C4d RUO | 27709 | TM09009 | TM09036 | 27417 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Complement C4d assay is an enzyme-linked immunosorbent assay (ELISA) for the semiquantitative determination of C4d in human plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of Amyloid ß Toxic Oligomer in cerebrospinal fluids. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Adalimumab (Humira®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Solid phase sandwich ELISA for the determination of Human Thioredoxin in serum, EDTA plasma, urine and cell culture supernatant. For research use only, not for use in diagnostic procedures. |
| Detection Target | Phospho Tau (181P) | Metanephrine / Normetanephrine | PSA (Total) | sAPP Total | Anti-Certolizumab pegol (Cimzia®) |
| Sample Type | Cerebrospinal fluids | Urine | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum and plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 5 - 400 ng/mL | 3.13 to 200.0 pg/mL | 0 / 5 - 150 ng/mL | Anti-Ustekinumab (Stelara®) | 3.91 to 250 ng/mL |
| Sensitivity | 1.9 pg/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | Inquire | 0.06 ng/mL | 40 ng/mL |
| Assay Time | 2 hours total incubation time. | 1 hr 30 mins (incubation) | 2 hours, 15 min. total incubation time. | 2 hour, 30 min. total incubation time. | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |